| Prof Janet L Chapman, MD | |
|
5130 Coolidge Hwy, Royal Oak, MI 48073-1001 | |
| (248) 288-9500 | |
| (248) 288-0044 |
| Full Name | Prof Janet L Chapman |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 5130 Coolidge Hwy, Royal Oak, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972723385 | NPI | - | NPPES |
| OF36464 | Other | MI | BCBS PROVIDER ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 4301039925 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Prof Janet L Chapman, MD 30932 Country Ridge Cir, Farmington Hills, MI 48331-1113 Ph: (248) 661-5292 | Prof Janet L Chapman, MD 5130 Coolidge Hwy, Royal Oak, MI 48073-1001 Ph: (248) 288-9500 |
News Archive
The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to commence.
PolyPid, a developer of innovative drug carriers, announced today the company's flagship platform – PolyPid. PolyPid is a new, innovative family of drug carriers, based on a fusion between two known drug delivery systems: polymers and lipid-based systems.
More than 80 percent of all waste from Pennsylvania's oil and gas drilling operations stays inside the state, according to a new study that tracks the disposal locations of liquid and solid waste from these operations across 26 years.
Anaplastic thyroid cancer is a rare form of thyroid tumor, but it is also the most deadly. Newly developed evidence-based recommendations for the diagnosis, treatment, and long-term monitoring and follow-up care of patients with this extremely aggressive form of thyroid cancer are published in Thyroid, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 6 days ago
Nicole Marijanovich, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-7999 Fax: 248-898-0580 | |
Vinayata Manuballa Kareti, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 661-948-0803 | |
Filip Ionescu, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3000 | |
Christopher Carpenter, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3535 W 13 Mile Rd Ste 605, Royal Oak, MI 48073 Phone: 248-551-0495 | |
Dr. Matthew Burns Cotant, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3577 W 13 Mile Rd, Suite 404, Royal Oak, MI 48073 Phone: 248-551-6900 Fax: 248-551-6909 | |
Geoffrey Prysak, MD, MPH Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-7999 | |
Taylor Schoenheit, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-6509 |